Clinical and Immunologic Activity of a Single Dose of Neoadjuvant PD-1 Blockade and Predictors of Clinical Outcomes in Resectable Melanoma. Clinical and Immunologic Activity of a Single Dose of Neoadjuvant PD-1 Blockade and Predictors of Clinical Outcomes in Resectable Melanoma
收藏NIAID Data Ecosystem2026-03-10 收录
官方服务：
资源简介：
To understand some of the potential determinants of anti-PD-1 response and resistance in this cohort we used Nanostring analysis to study/compare the expression of custom set of genes Overall design: Samples from patients with varying clinical and response characteristics were used to study their gene expression profiles using Custom Nanostring panel of genes
创建时间：
2018-12-12
